Medtech device units get three months to revise MRP

THE CENTRAL DRUGS regulator on Thursday issued an order to the medical device manufacturers giving a three-month window to the industry to sticker their inventory with the revised retail sale price (MRP) that will reflect the reduced goods & services tax (GST) rates.

- MANU KAUSHIK

The order covers both importers and manufacturers of class C and D medical devices.

Class C and D medical devices are categorized as moderate-high risk and high-risk devices, respectively, that include products like bone fixation implants, diagnostic equipment like CT scan and MRI machines, pacemakers, defibrillators and implantable stents.

The order has also directed the state drugs controller to expedite the process of issuing no-objection certificates to manufacturers to alter the labels (stickers).